Talphera (TLPH) Operating Margin (QoQ) (2014 - 2023)
Powered by 
Analysis
Talphera (TLPH) Operating Margin (QoQ) (2014 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 130,401.00 |
| Sep 30, 2023 | -125,943.00 |
| Mar 31, 2022 | 40.67 Mn |
| Dec 31, 2021 | -40.83 Mn |
| Sep 30, 2021 | 179,708.00 |
| Jun 30, 2021 | -47,168.00 |
| Mar 31, 2021 | -53,647.00 |
| Dec 31, 2020 | -59,198.00 |
| Sep 30, 2020 | -42,688.00 |
| Jun 30, 2020 | 387,198.00 |
| Mar 31, 2020 | -94,949.00 |
| Dec 31, 2019 | -93,022.00 |
| Sep 30, 2019 | -80,611.00 |
| Jun 30, 2019 | 322,843.00 |
| Mar 31, 2019 | -285,760.00 |
| Dec 31, 2018 | 68,357.00 |
| Sep 30, 2018 | -159,982.00 |
| Jun 30, 2018 | 153,634.00 |
| Mar 31, 2018 | -135,579.00 |
| Dec 31, 2017 | -45,910.00 |